Birkmayer USA Secures Exclusive USA Rights for NEW Improved Stabilized
CARLSBAD, Calif., June 17 /PRNewswire/ -- Birkmayer USA, the US leading manufacturer and distributor of nadh branded nutritional products, has obtained the exclusive distribution of the patented stabilized product ENADA NADH (nicotinamide adenine dinucleotide hydride) for the USA. ENADA NADH was the original nadh product, stabilized by Prof. Jorge Birkmayer, and which created the nadh market in the USA and the world.
The NEW ENADA nadh product has now been improved by having a GRAS (Generally Recognized as Safe) status enteric coating which improves the product more naturally than previously.
The new ENADA nadh helps promote optimal absorption, allowing individuals to achieve maximum cellular energy benefits; furthermore it contains no: sugar, starch, salicylates, wheat, gluten, corn, egg, soy, casein, caffeine, yeast, dairy, preservatives, artificial colors, or flavors. From studies conducted by Dr. Birkmayer and associates stabilized NADH enhances the activity in organs that develop a high metabolic turnover, like the brain, the circulation system, and muscles.(*)
Also known as coenzyme 1 (Co-E1), NADH is a highly specialized form of the B-vitamin niacin that is found in all living cells. It plays a key role in the energy production of cells and neurotransmitter processes. Stabilized, intact NADH appears to work by entering "fatigued" cells to promote cellular energy production in the form of ATP (adenosine triphosphate), a nucleotide that facilitates intracellular energy transfer.(*)
Birkmayer USA is announcing the introduction of 5mg ENADA NADH which is
available end of June 2008. Other nadh products sold by Birkmayer USA are
the Co-E1 NADH brand of 5mg Enteric coated and also the Sublingual Co-E1
NADH 10mg and 20mg tablets. The sublingual nadh products are ONLY sold and
distributed by Birkmayer USA and are
|SOURCE Birkmayer USA|
Copyright©2008 PR Newswire.
All rights reserved